Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.17 -0.12 (-9.30%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Return on Equity [ROE] (2014 - 2026)

Updated

Aldeyra Therapeutics' Return on Equity [ROE] was -57.60% in Q2 2026, up 27.55 percentage points from -85.15% a year earlier and up 5.75 percentage points from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Return on Equity [ROE] (2014 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Aldeyra Therapeutics came in at -58.73%, down 0.19 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of +11.08 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -58.54% in FY2024 (-30.82 pp), -27.73% in FY2023 (+7.05 pp), -34.77% in FY2022 (+8.79 pp) and -43.56% in FY2021 (+26.24 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q3 2024.
  • Compared with a year earlier, Return on Equity [ROE] was higher in two of the last eight quarters, with an average year-over-year change of -18.43 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 41.13 percentage points); the worst was Q1 2025 (a drop of 60.00 percentage points).
  • Per Business Quant data, ALDX's Return on Equity [ROE] in the three quarters before Q2 2026 was -63.35% (Q1 2026), -72.40% (Q4 2025) and -82.64% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Aldeyra Therapeutics 70.58 Mn 70.58 Mn - -57.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.60%
Mar 31, 2026 -63.35%
Dec 31, 2025 -72.40%
Sep 30, 2025 -82.64%
Jun 30, 2025 -85.15%
Mar 31, 2025 -85.73%
Dec 31, 2024 -71.56%
Sep 30, 2024 -48.85%
Jun 30, 2024 -35.77%
Mar 31, 2024 -25.74%
Dec 31, 2023 -30.92%
Sep 30, 2023 -36.14%
Jun 30, 2023 -38.98%
Mar 31, 2023 -42.22%
Dec 31, 2022 -39.61%
Sep 30, 2022 -38.59%
Jun 30, 2022 -36.26%
Mar 31, 2022 -31.92%
Dec 31, 2021 -27.16%
Sep 30, 2021 -23.52%
API Access

Aldeyra Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALDX&period=max&api_key=YOUR_API_KEY